Clinical trial
Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus…
NCT00139386 · Kumamoto University, Other · Completed
Key facts
| NCT number | NCT00139386 |
|---|---|
| Title | Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial |
| Official title | Effects of Candesartan Cilexetil on Cardiovascular Events in Japanese Patients With Hypertension After Sirolimus- or Paclitaxel-Eluting Stents Implantation |
| Lead sponsor | Kumamoto University, Other |
| Collaborators | The 4C trial bureau Japan Heart Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Candesartan |
| Enrollment | 1,119 |
| Start date | Oct 1, 2005 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2012 |
| First posted | Aug 31, 2005 |
| Last update posted | Apr 18, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: